Global Neurology Academy - Global Neurology Academy

Global Neurology Academy

Global Neurology Academy

Enhance your practice with CME
and tools that focus on the management
of neurological conditions.

Popular

Recognizing the Signs of TK2 Deficiency
Recognizing the Signs of TK2 Deficiency
NeuroFrontiers
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
- Kaitlin Batley, MD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
CME/CE
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
0.25 credits
- R. Scott Turner, MD, PhD
0.25 credits
The Role of B-Cell Depletion in MS Care
The Role of B-Cell Depletion in MS Care
NeuroFrontiers
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
- David Hafler, MD, FANA, MSc
Exploring Genetic Links Between EBV Clearance and MS Risk
Exploring Genetic Links Between EBV Clearance and MS Risk
NeuroFrontiers
Exploring Genetic Links Between EBV Clearance and MS Risk
David Hafler, MD, FANA, MSc
- David Hafler, MD, FANA, MSc
Implementing Cognitive Screening in MS Care
Implementing Cognitive Screening in MS Care
NeuroFrontiers
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
- Elizabeth S. Gromisch, PhD
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
CME/CE
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS; Valeria Caso, MD, PhD
0.75 credits
- C. Michael Gibson, MD, MS
- Valeria Caso, MD, PhD
- Ashkan Shoamanesh, MD
0.75 credits
Discharge Planning After Myasthenic Crisis
Discharge Planning After Myasthenic Crisis
NeuroFrontiers
Discharge Planning After Myasthenic Crisis
Qihua Fan, MD
- Qihua Fan, MD
The New Era of Targeted Therapy for Myasthenia Gravis
The New Era of Targeted Therapy for Myasthenia Gravis
NeuroFrontiers
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS

Medical News

Medical News
Falls Lead Head, Face, and Neck Injury Cases in NEISS Analysis
11/02/2026
Read more
$Simplified skull illustration highlighting a facial fracture in a restrained clinical color palette$
Medical News
Concomitant Injuries in 31.7% of Facial Fracture Patients
10/26/2026
Read more
Medical News
SCC-DBS Pathway Engagement Linked to Depression Response
10/23/2026
Read more
Medical News
Dystonia in PSP: Subtype Patterns and MRI Associations
10/20/2026
Read more

CME/CE

Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
CME/CE
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
0.25 credits
- Dani Cabral, MD
0.25 credits
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Broadcast Replay
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD; David Weisman, MD
1.00 credit
- Dani Cabral, MD
- David Weisman, MD
1.00 credit
Recurrence as the Rule: BD Symptoms Persist and Cycle
Recurrence as the Rule: BD Symptoms Persist and Cycle
MinuteCE®
Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
MinuteCE®
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits

Clinical Practice

Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
NeuroFrontiers
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Kaitlin Batley, MD
- Kaitlin Batley, MD
Uncovering TK2d: How to Navigate Diagnostic Challenges
Uncovering TK2d: How to Navigate Diagnostic Challenges
NeuroFrontiers
Uncovering TK2d: How to Navigate Diagnostic Challenges
Kaitlin Batley, MD
- Kaitlin Batley, MD
A Closer Look at the Biology Behind MS Progression
A Closer Look at the Biology Behind MS Progression
NeuroFrontiers
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
- Ethan Meltzer, MD
Immunologic Phenotyping: The Future of Personalized MG Care
Immunologic Phenotyping: The Future of Personalized MG Care
NeuroFrontiers
Immunologic Phenotyping: The Future of Personalized MG Care
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS

Programs

Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
NeuroFrontiers
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Ethan Meltzer, MD
- Ethan Meltzer, MD
Precision Medicine for Myasthenia Gravis
Precision Medicine for Myasthenia Gravis
NeuroFrontiers
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS
Outcome Measures Capture Progression in Late-Onset TK2d
Outcome Measures Capture Progression in Late-Onset TK2d
NeuroFrontiers
Outcome Measures Capture Progression in Late-Onset TK2d
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
AudioAbstracts
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Ryan Quigley
- Ryan Quigley